Green Plus Co., Ltd. (KOSDAQ:186230)
3,465.00
-55.00 (-1.56%)
At close: Jun 18, 2026
Green Plus Revenue
Green Plus had revenue of 31.56B KRW in the quarter ending March 31, 2026, with 42.96% growth. This brings the company's revenue in the last twelve months to 115.20B, up 25.36% year-over-year. In the year 2025, Green Plus had annual revenue of 105.72B with 20.56% growth.
Revenue (ttm)
115.20B
Revenue Growth
+25.36%
P/S Ratio
0.32
Revenue / Employee
669.77M
Employees
172
Market Cap
37.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 105.72B | 18.03B | 20.56% |
| Dec 31, 2024 | 87.68B | 28.81B | 48.93% |
| Dec 31, 2023 | 58.87B | -24.13B | -29.07% |
| Dec 31, 2022 | 83.01B | -230.65M | -0.28% |
| Dec 31, 2021 | 83.24B | 20.56B | 32.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KB Autosys | 221.17B |
| Carelabs Co.,Ltd | 79.17B |
| TKG Aikang | 70.50B |
| KD Chem | 64.11B |
| Korean Drug | 62.76B |
| Biotoxtech | 47.64B |
| TBC | 40.39B |
| Precision Biosensor | 22.34B |